Oral ganciclovir in the prevention of cytomegalovirus infection in postkidney transplant 'CMV at risk' recipients: A controlled, comparative study of two regimens (750 mg Bid and 500 mg Bid)

N. Ahsan, M. J. Holman, L. Sonderbye, E. Langhoff, H. C. Yang

Research output: Contribution to journalArticlepeer-review

21 Scopus citations
Original languageEnglish
Pages (from-to)1383-1385
Number of pages3
JournalTransplantation Proceedings
Issue number4
StatePublished - 1998
Externally publishedYes

Cite this